Gregg Boyle

Week of June 28 - July 4 This was a consolidation week, and we held the line on evidence rather than filling space with announcements. What is left, read from the top of the stack down, tells one coherent story. At the top, the deployments that survived scrutiny share a trait:

Week of June 21 to 27, 2026 This was a consolidation week, not a breakthrough one, and the absence of a blockbuster is itself the signal. Nothing in this weeks announcements cleared an 8.0, and the top tier capped at 7.8. What happened instead is more structural and

For three years, healthcare AI has been graded on a curve. A slick demo on a conference stage. A flattering pilot with a hand-picked denominator. A benchmark score on a dataset the model never has to face in a real clinic on a busy Tuesday. The pitch was always

Week of June 7-13, 2026 Federal AI oversight stopped being a proposal this week and became a permanent office, a coding system, and a defunding vote. In this newsletter we have tracked the rules "arriving" since March. Governance as scale advantage in March, the new reimbursement rules

Week of May 31 to June 6, 2026 This was the week AI stopped asking permission. In the span of a few days, the question shifted from whether AI can perform clinical work to whether institutions are ready to let it act on its own. The clearest signal came from

Healthcare AI Signal: Surfacing the real signals shaping AI in healthcare Week of May 24–30, 2026 This week, two of the three gates that move AI from promise to scale swung open, and the third stayed shut. The FDA cleared a wave of specialist-level diagnostic AI (noninvasive heart-